Skip to main content
. 2016 Oct 1;16(4):327–338. doi: 10.1007/s40268-016-0144-x

Fig. 6.

Fig. 6

Relative effectiveness of microneedle (MN) patches to subcutaneous injections (SC Inj.) and average costs per case of measles averted. Note: Effectiveness of SC Inj. held constant for cost comparison of MN patches at different levels of efficiency relative to existing syringe-and-needle technology. Cost of illness is not included in the analysis